Pharmaceuticals, Biotechnology and Life Sciences
COLOGNE, Germany–(BUSINESS WIRE)–On September 9th, Cannamedical® Pharma GmbH, a leading cannabis distributor and one of the best-known medicinal cannabis brands…
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia–(BUSINESS WIRE)–Date of conference call should read:…
EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical cannabis company, is pleased to announce that Medalchemy, EMMAC’s fully-licensed GMP certified laboratory in Alicante, Spain, has secured approval from the Spanish Health Authorities AEMPS to import medical cannabis for scientific research.
The Israeli Parliament, the Knesset, on December 25th, passed a bill that concerns the governance and regulatory aspects of exporting medical cannabis from Israel, said on Wednesday a manufacturer of automated commercial growing devices for medical grade cannabis, Seedo Corp.
Emblem Corp, licensed producer and distributor of medical cannabis and cannabis derivatives in Canada, said Monday that that its director…
GW Pharmaceuticals, a biopharmaceutical company focused on making and selling therapeutics from its cannabinoid product platform, said Monday that the…
The legal cannabis market was worth an estimated $6.6 billion in 2016, and is projected to grow at a compound annual growth rate (CAGR) of 16% or reaching more than $24 billion by 2025.